StockNews.AI
QIPT
StockNews.AI
74 days

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Quipt Home Medical Corp. - QIPT

1. Pomerantz LLP investigates potential securities fraud at Quipt Home Medical Corp. 2. Forager Capital Management demands retraction of misleading statements by Quipt. 3. Quipt's stock fell 8.53% following news of the investigation. 4. The investigation raises serious concerns over Quipt's business practices. 5. Investors are encouraged to join the class action against Quipt.

3m saved
Insight
Article

FAQ

Why Very Bearish?

The stock price drop indicates significant investor concern. Historically, similar investigations lead to prolonged price declines.

How important is it?

The securities fraud investigation directly concerns Quipt's management and may significantly affect investor confidence.

Why Short Term?

Immediate reactions to investigations often lead to volatility. Long-term effects depend on the outcome of these claims.

Related Companies

FORGAVGROMED
NEW YORK, June 06, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Quipt Home Medical Corp. (“Quipt” or the “Company”) (NASDAQ: QIPT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Quipt and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class action] On June 5, 2025, Forager Capital Management (“Forager”), one of Quipt’s largest shareholders, issued a press release stating its “request[] that Quipt immediately and unequivocally retract its false and misleading statement made in its press release on May 21, 2025 relating to Forager's offer to acquire 100% of Quipt's issued and outstanding common shares at a price of $3.10 per common share.” On this news, Quipt’s stock price fell $0.18 per share, or 8.53%, to close at $1.93 per share on June 5, 2025. Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com. Attorney advertising. Prior results do not guarantee similar outcomes. CONTACT:Danielle PeytonPomerantz LLPdpeyton@pomlaw.com646-581-9980 ext. 7980

Related News